Dr. Shub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 E Thomas Rd
Phoenix, AZ 85016Phone+1 602-933-0940Fax+1 602-933-2424
Summary
- Mitchell Shub, MD is a Pediatric Gastroenterologist based in Phoenix, AZ. He completed his gastroenterology fellowship at Massachusetts General Hospital and pediatric residency at Duke University Hospital. Dr. Shub is skilled in managing gastroesophageal reflux, malabsorption syndromes, esophagitis, esophagoscopy, and risk management. He has a strong research portfolio with multiple papers published in high impact journals, including extensive studies on microvillus inclusion disease. His most cited work is related to MYO5B gene and enterocytes, cited 38 times. Dr. Shub, Professor and former Chair of the Department of Child Health at the University of Arizona College of Medicine-Phoenix, also received the honor of being the Commencement Speaker at the University of Arizona College of Medicine-Phoenix in 2017.
Education & Training
- Massachusetts General HospitalFellowship, Gastroenterology, 1979 - 1982
- Duke University HospitalResidency, Pediatrics, 1976 - 1979
- University of Vermont College of MedicineClass of 1976
Certifications & Licensure
- AZ State Medical License 1985 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Comnmencement Speaker University of Arizona College of Medicine-Phoenix, 2017
Publications & Presentations
PubMed
- 1 citationsMyosin Vb Traffics P-Glycoprotein to the Apical Membrane of Intestinal Epithelial Cells.Sarah A Dooley, Elena Kolobova, Andreanna Burman, Izumi Kaji, Jessica R Digrazia
Gastroenterology. 2025-01-01 - Development and validation of a stakeholder-driven, self-contained electronic informed consent platform for trio-based genomic research studies.Bethany Y Norton, James Liu, Sara A Lewis, Helen Magee, Tyler N Kruer
Medrxiv. 2024-05-03 - 2 citationsPatient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.Meri Kalashyan, Krishnan Raghunathan, Haley Oller, Marie-Theres Bayer, Lissette Jimenez
The Journal of Clinical Investigation. 2023-10-16
Journal Articles
- MYO5B Uncoupling from Rab8a and Rab11a Elicits Microvillous Inclusion DiseaseKnowles, B., Roland, J., Krishnan, M., Tyska, M., Lapierre, L., Dickman, P.,, J. Clin. Invest., 7/2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: